Treating HIV infection with drugs for HSV-2 infection? (Q38927414)

7 September 2017

title

Treating HIV infection with drugs for HSV-2 infection? (English)

1 reference

7 September 2017

1 reference

Anne Buvé

1

1 reference

7 September 2017

Lutgarde Lynen

series ordinal

2

1 reference

7 September 2017

language of work or name

English

0 references

publication date

12 February 2010

1 reference

7 September 2017

1 reference

7 September 2017

volume

375

1 reference

7 September 2017

issue

9717

1 reference

7 September 2017

page(s)

782-784

1 reference

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

A randomized trial of multivitamin supplements and HIV disease progression and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

Follow-up of HIV-infected women diagnosed by antenatal screening in Barbados from 1996-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960097-9

7 January 2021

10.1016/S0140-6736(10)60097-9

Identifiers

DOI

1 reference

7 September 2017

1 reference